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Aim: The moisturizing properties of glycerol, the penetration enhancing capability of propylene glycol
and the bioadhesive properties of mucin were combined to improve the carrier capabilities of transfer-
somes and the efficacy of mangiferin in the treatment of skin lesions. Materials & methods: Mangiferin
was incorporated in transfersomes and glycoltransfersomes, which were also modified with mucin. The
physico–chemical features were assessed, along with the efficacy against oxidative stress and skin wounds
in vitro and in vivo. Results: Glycoltransfersomes promoted the deposition of mangiferin in epidermis and
dermis, protected fibroblasts from oxidative stress and stimulated their proliferation. The wound healing
and anti-inflammatory efficacy of glycoltransfersomes were confirmed in vivo. Conclusion: Results con-
firmed the potential of glycoltransfersomes in preventing/treating of skin lesions.
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Traditional folk medicine still provides suitable therapies for millions of people worldwide through the use of
natural compounds with therapeutic or beneficial properties. Given that, plant extracts and natural molecules have
been attracting the interest of researchers [1]. Recent studies have underlined the importance of nanomedicine in
potentiating the efficacy of natural compounds by the enhancement of their pharmacokinetics and bioavailability
at the target tissue [2–5]. Pharmaceutical nanotechnologies can innovate traditional health-promoting preparations,
helping to overcome challenges and ensuring their translation from bench to clinical application. Among the
different nanosystems explored over the years, phospholipid vesicles represent one of the most valuable and
versatile systems, especially for skin delivery, owing to their structure, biocompatibility and similarity to skin
components [6–9]. Over the last three decades, new kinds of phospholipid vesicles have been proposed, such
as ultra-deformable vesicles, namely transfersomes, for the transdermal delivery of drugs [10]. Transfersomes are
more elastic and deformable than conventional liposomes, due to the presence of an edge activator, which is
a surfactant or another molecule capable of modifying the assembly of the bilayer. Other phospholipid vesicles
have been proposed to improve dermal and transdermal delivery of drugs [8]. Ethosomes are soft vesicles prepared
by using a blend of ethanol and water as hydrating medium of phospholipids [11–13]. Transethosomes have been
developed by combining ethanol and an edge activator to improve the deformability of vesicles [14]. Penetration
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enhancer-containing vesicles have been formulated to facilitate skin delivery of bioactive molecules: they contain
a penetration enhancer (e.g., propylene glycol or ethylene glycol) that intercalates the bilayer or blends in the
aqueous medium [15,16]. Glycerosomes have also been formulated for skin delivery by using mixtures of water and
glycerol [17].
All these vesicles have been tested as carriers for drugs, natural molecules and extracts with antioxidant and anti-
inflammatory properties, showing promising capabilities in the treatment of skin disorders [18–21]. In particular,
the delivery of natural bioactive molecules, such as curcumin, resveratrol, quercetin, baicalin and mangiferin in
phospholipid vesicles was found to be advantageous for the treatment of skin lesions [22–24].
Among the existing natural antioxidants, mangiferin is less used and studied in modern phytotherapy, despite its
wide use in traditional Chinese herbal preparations [25]. Mangiferin is a glucosylxanthone (2-β-D-glucopyranosyl-
1,3,6,7-tetrahydroxy-9H-xanthen-9-one) isolated from higher plants, as well as from mango leaves, fruits and
by-products (i.e., peel and kernel seed). Research has shown the antioxidant, anti-inflammatory, antidiabetic,
anticancer, antimicrobial, analgesic and immunomodulatory properties of mangiferin [26,27]. However, mangiferin
has a very low solubility in aqueous media (0.111 mg/ml) [28] and poor lipophilicity [29], and its efficacy in vivo
is hampered by low absorption and high speed of clearance. The bioavailability at skin level is low and, when
applied as a cream or gel, it hardly crosses the stratum corneum (SC) and remains on the skin surface [30,31]. For
these reasons, the incorporation of mangiferin in phospholipid vesicles represents a valuable approach to increase
its bioavailability and absorption at skin level. To this purpose, transfersomes can be effectively employed, since
they are phospholipid vesicles specifically designed for dermal and transdermal delivery. The novelty of this work
lies in the fact that, differently from what has been proposed previously, we modified transfersomes by adding
three key components: glycerol, propylene glycol and mucin to improve the penetration enhancing capabilities, the
stability and the mucoadhesive properties [32,33] of the vesicles. Glycerol is a well-known moisturizing agent that
increases the hydration of human skin [34], and an osmolyte that stabilizes fluid structures in phospholipid bilayer
systems (both skin lamellar pathways and vesicle carriers) [35]. Propylene glycol is a water-soluble, biocompatible
penetration enhancer widely used in pharmaceutical preparations; it is able to improve drug permeation through
the skin from topical preparations [36]. Mucins are large glycoproteins ubiquitous in the animal kingdom, which
can exert barrier, hydration, adhesion and lubrication properties [37]. Glycerol and propylene glycol have been
previously used individually to ameliorate the performance of phospholipid vesicles, but, in this work, they were
used in combination, either in the presence or absence of mucin, to modify transfersomes for the delivery of
mangiferin to the skin. Transfersomes, used as a reference, were prepared by adding Tween 80 to phospholipid
vesicles. Tween 80 acts as an edge activator, modifying the bilayer assembly and fluidity. Glycoltransfersomes and
mucin-glycoltransfersomes were formulated by combining transfersomes with the glycols and mucin. The vesicles
were fully characterized, and their ability to improve the skin delivery of mangiferin and its efficacy in repairing
damaged skin were evaluated in vitro and in vivo.
Materials & methods
Materials
Soy lecithin, glycerol, propylene glycol and Tween 80 were purchased from Galeno Srl (Milan, Italy). Mucin from
porcine stomach (640 kDa), mangiferin, HPLC-grade methanol and hydrochloric acid, 3-(4,5-dimethylthiazol-2-
yl)-3,5 diphenyl tetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), 12-O-tetradecanoylphorbol 13-acetate
(TPA) and all the other reagents of analytical grade were purchased from Merck Life Science Srl (Milan, Italy).
Cell medium, fetal bovine serum, penicillin, streptomycin and all the other reagents for cell studies were purchased
from Thermo Fisher Scientific Inc. (MA, USA).
Vesicle preparation
Glycoltransfersomes were prepared in two steps. In the first step, mangiferin (20 mg) was weighed in a glass vial
and dispersed in a hydrating blend (2 ml) of water, glycerol and propylene glycol (25:25:50, %v/v) and sonicated
(25 cycles, 5 s on and 2 s off, 13 microns of probe amplitude) by using a high intensity ultrasonic disintegrator
(Soniprep 150, MSE Crowley, London, UK). In the second step, 360 mg of phospholipid and 40 mg of Tween 80
were weighed in a glass vial, the mangiferin in the water, glycerol and propylene glycol blend was added, and the
final dispersion was sonicated (25 cycles, 5 s on and 2 s off, 13 microns of probe amplitude). The composition of
samples is reported in Supplementary Table 1.
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Transfersomes (used as a reference) were prepared by dispersing the phospholipid (360 mg), Tween 80 (40 mg)
and mangiferin (20 mg) in water (2 ml), and sonicating the dispersion (25 cycles, 5 s on and 2 s off, 13 microns of
probe amplitude) [38]. In addition, muc-glycoltransfersomes and muc-transfersomes were prepared by adding the
polymer (mucin, 2 mg/ml) to the disperions.
Each vesicle dispersion (2 ml) was loaded into Spectra/Por R© membranes (12–14 kDa MW cutoff, 3-nm pore
size; Spectrum Laboratories Inc., DG Breda, The Netherlands) and dialysed against water (2 l) for 2 h (with water
refreshed after 1 h) at room temperature, to remove the nonincorporated mangiferin [39].
Vesicle characterization
Cryo-TEM analyses were performed to evaluate vesicle formation and morphology. Each vesicle dispersion, properly
diluted with water, was placed on a glow-discharged holey carbon grid and vitrified with ethane by using a Vitrobot
System (FEI Company, Eindhoven, The Netherlands). The vitreous film was observed under a transmission
electron microscopy (TEM) microscope (Tecnai F20, FEI Company) in a low-dose mode at 200 kV and at
approximately -173◦C.
The average diameter and polydispersity index (PI) (i.e., a measure of the size distribution width) of the vesicles
were determined by Dynamic Light Scattering using a Zetasizer nano-ZS (Malvern Instruments, Worcestershire,
UK), which uses a helium-neon laser (633 nm) with a 173◦ scattering angle and backscatter technology for high
sensitivity. The ζ potential (ZP) was estimated by electrophoretic light scattering using the Zetasizer nano-ZS,
which measures the electrophoretic mobility of particles in dispersion. The measurements were carried out at 25◦C
after a 1:100 dilution of the samples with the dispersing medium used for their preparation (water or water, glycerol
and propylene glycol blend) [40].
The stability of the vesicles was assessed by monitoring the mean diameter (MD), PI and ZP over 6 months at
25 ± 1◦C.
Entrapment efficiency was expressed as the percentage of mangiferin recovered after dialysis versus the amount
found in nondialysed samples. Mangiferin was quantified by HPLC after disruption of nondialysed and dialysed
vesicles with methanol (1:100 dilution), using a Perkin Elmer Flexar chromatograph (Madrid, Spain) equipped
with a UV detector and a column Brisa LC2 C18 (5 μm, 15 × 0.46 cm; Teknokroma, Barcelona, Spain). The
isocratic mobile phase consisted of a mixture of hydrochloric acid (pH 4.0) and methanol (60:40, v/v), the flow
rate was 1.2 ml/min, and the injection volume was 20 μl. The detection wavelength was set at 254 nm. Standard
calibration curves covering the whole mangiferin range concentrations were built. The obtained calibration graphs
showed a good linearity (R2 = 0.99). The limits of detection and quantification were estimated using the calibration
curve procedure and were 0.21 and 0.54 μg/ml, respectively. Accuracy was evaluated in terms of error relative and
precision by means of coefficient of variation, both values were less than 7%.
Evaluation of skin delivery performances of mangiferin-loaded vesicles
Experiments were performed by using newborn pig skin provided by a local slaughterhouse. The skin was stored
at -80◦C after excision, defrosted and pre-equilibrated at 37◦C in saline 2 h before the experiments. The full-
thickness skin specimens (n = 6 per formulation) were sandwiched between the donor and receptor compartments
of Franz vertical cells with an effective diffusion area of 0.784 cm2. The receptor compartment was filled with
an aqueous solution of Tween 80 (1%; ∼6 ml), which was continuously stirred with a small magnetic bar and
thermostated at 37 ± 1◦C throughout the experiment to reach the physiological temperature (i.e., 32 ± 1◦C) of
the skin surface [41]. The mangiferin formulations were applied (200 μl) onto the skin surface, under nonocclusive
conditions. A dispersion of mangiferin in a water, glycerol and propylene glycol blend (25:25:50, %v/v) was used
as a reference. Every 2 h and up to 24 h, the receiving solution was withdrawn, replaced with an equal volume of a
fresh solution, and analyzed by HPLC for mangiferin content (see ‘Vesicle characterization’ section). At the end of
the experiment, the skin surface was gently washed with water and blotted dry on absorbent paper. SC was stripped
with adhesive tape (Tesa R© AG, Hamburg, Germany) and epidermis was separated from dermis with a scalpel. The
tape strips, epidermis and dermis were cut, placed separately in vials containing methanol and sonicated in an ice
bath (2 min) to extract mangiferin. After filtration, the solutions were assayed for mangiferin content by HPLC
(see ‘Vesicle characterization’ section) [21].
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Evaluation of biocompatibility & protective effect of mangiferin-loaded vesicles against oxidative
damage in vitro
Mouse embryonic fibroblasts (3T3) (ATCC collection, VA, USA) were grown as monolayers in 75-cm2 flasks
incubated with 100% humidity and 5% CO2 at 37◦C. DMEM with high glucose, 10% fetal bovine serum,
1% penicillin or streptomycin and fungizone, was used to culture the cells. Cell viability was measured by the
3-(4,5-dimethylthiazol-2-yl)-3,5 diphenyl tetrazolium bromide (MTT) test [42]. The cells (7.5 × 103/well) were
seeded into 96-well plates, cultured for 24 h and exposed for 48 h to the samples (i.e., mangiferin in a water,
glycerol and propylene glycol dispersion, or loaded in vesicles) properly diluted with medium to achieve the
desired concentration of mangiferin (10, 1, 0.1 and 0.01 μg/ml). Thereafter, an MTT solution (0.5 mg/ml final
concentration) was added to each well, removed after 3 h and replaced with DMSO, then the absorbance of the
solubilized dye was read at 570 nm with a microplate reader (Multiskan EX, Thermo Fisher Scientific Inc.). The
results are shown as a percentage of live cells in comparison with untreated control cells (100% cell viability).
To evaluate the protective ability of the vesicles against oxidative damage, the cells were seeded into 96-well
plates, incubated for 24 h and exposed simultaneously to hydrogen peroxide (1:50,000 dilution) and mangiferin
in a water, glycerol and propylene glycol dispersion or loaded in vesicles (1 μg/ml mangiferin). After 4 h, the cells
were washed with phosphate-buffered solution (PBS), and the MTT assay was performed to evaluate the protective
effect of the mangiferin samples against death caused by oxidative stress [21]. Untreated cells (100% viability) were
used as a negative control, and cells exposed to hydrogen peroxide only were used as a positive control.
Scratch wound healing assay
The wound healing properties of the vesicle formulations was assessed by measuring the expansion of fibroblasts
on the wound surface. 3T3 cells were grown in six-well plates to form a confluent monolayer, and a mechanical
wound was created by scratching with a sterile plastic pipette tip. Cell fragments were gently washed out with fresh
medium. The cells were incubated with the vesicle formulations for 48 h. Untreated cells were used as a control, as
well as cells treated with a dispersion of mangiferin in a water, glycerol and propylene glycol blend. The rate of cell
migration leading to wound closure was observed under a light microscope with a 10× objective, capturing images
at scheduled intervals, thus assessing the efficacy of the vesicle formulations in wound healing.
Evaluation of protective effect of mangiferin-loaded vesicles against skin damage in vivo
For the inflammation study, female CD-1 mice (5–6 weeks old, 25–35 g) were supplied by Envigo laboratories
(Barcelona, Spain). Mice were acclimatized for 1 week before use. The experiments were performed in accordance
with the European regulations for handling and use of laboratory animals, and the protocols were approved by the
Institutional Animal Care and Use Committee of the University of Valencia (code 2018/VSC/PEA/0032 type 2).
The mice (n = 4) were divided in groups, including untreated animals (negative control), animals treated with TPA
and saline (positive control), and animals treated with the vesicle formulations or a dispersion of mangiferin in a
water, glycerol and propylene glycol blend. The back skin of mice was shaved 1 day before the experiment. On
day 1, cutaneous inflammation and lesion were induced by applying 12-O-tetradecanoylphorbol 13-acetate (TPA;
20 μl) dissolved in acetone (243 μM) on the shaved area (∼2 cm2). After 3 h, 200 μl of each sample was topically
smeared over the TPA-treated area until complete absorption. The procedure was repeated on day 2 and 3. On
day 4, mice were sacrificed by cervical dislocation, and the treated skin area was excised and immediately stored at
-80◦C.
The myeloperoxidase (MPO) activity, a quantitative assessment of neutrophil infiltration into the skin, was
measured [40]. Mouse skin biopsies were homogenized and centrifuged, the supernatant (10 μl) was incubated with
sodium phosphate buffer (pH 5.4; 20 μl), phosphate buffer (pH 7.4; 200 μl), 0.052% hydrogen peroxide (40 μl)
and 18 mM 3,30,5,50-tetramethylbenzidine dihydrochloride (20 μl). The reaction was stopped by adding 2 N
H2SO4 (50 μl). The absorbance was read at 450 nm. The MPO activity was calculated from the linear portion of
a standard curve and expressed as ng/ml.
Histological examination
Skin biopsies (see ‘Evaluation of protective effect of mangiferin-loaded vesicles against skin damage in vivo’ section)
were excised from the treated mice dorsal region, after 72 h of treatment (on day 4) and maintained in formaldehyde
(10% v/v) for microscopic studies. Tissue samples were processed routinely and embedded in paraffin wax.
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Figure 1. Cryo-transmission electron microscopy images. Representative images of mangiferin-loaded vesicles: transfersomes (A),
glycoltransfersomes (B), muc-transfersomes (C), muc-glycoltransfersomes (D).
Longitudinal sections (5 μm) were stained with hematoxylin and eosin. Microscopic assessment by light microscope
was performed blind on coded slices.
Statistical analysis of data
Results are expressed as means ± standard deviations. Analysis of variance was used to evaluate multiple comparison
of means and Tukey’s test and Student’s t-test were performed to substantiate differences between groups using
XLStatistics for Windows. The differences were considered statistically significant for p < 0.05.
Results
Vesicle preparation & characterization
A pre-formulation study was carried out using different types and amounts of phospholipid, edge activators
and water cosolvents. Among the numerous formulations tested, the vesicles made of soy lecithin (180 mg/ml),
mangiferin (10 mg/ml) and Tween 80 (20 mg/ml) in a blend of water, glycerol and propylene glycol (25:25:50%
v/v) were selected based on their small size and stability. Given their composition, the vesicles were named
glycoltransfersomes. Transfersomes with the same concentration of soy lecithin, mangiferin and Tween 80 were
prepared as a reference. Furthermore, transfersomes and glycoltransfersomes were modified by the addition of
mucin, which is expected to ameliorate the adhesion of the vesicles to skin and cells [43,44].
Cryo-TEM observation confirmed the formation of lamellar vesicles (Figure 1). In particular, in transfersomes
(Figure 1A), unilamellar, fairly spherical, small vesicles were observed; in glycoltransfersomes and muc-transfersomes
(Figure 1B & C), uni- and oligolamellar vesicles coexisted with multivesicular structures; in muc-glycoltransfersomes
(Figure 1D), multilamellar, larger and more irregularly shaped vesicles were evident. These results suggest that the
addition of glycols and mucin impact the morphology of the vesicles.
The MD, PI, ZP and entrapment efficiency of the vesicles were first evaluated (Table 1). Empty vesicles
(i.e., without mangiferin) were prepared and characterized to evaluate the effect of the payload on the vesicle
assembly.
Transfersomes were the smallest vesicles (∼75 nm; Table 1) and their size was not affected by the presence of
mangiferin or mangiferin and mucin together (p > 0.05 among empty transfersomes, mangiferin transfersomes
and mangiferin muc-transfersomes). The addition of mucin, without mangiferin, caused an increase in the MD
of muc-transfersomes (∼150 nm, p < 0.05 vs the other transfersomes; Table 1). Empty glycoltransfersomes and
empty muc-glycoltransfersomes showed the largest MD (292 and 238 nm, respectively). Both systems underwent a
decrease in size upon addition of mangiferin: the decrease was strong in the case of glycoltransfersomes (∼100 nm)
and much less marked in the case of muc-glycoltransfersomes (∼210 nm). The vesicle enlargement seems to be
dependent on the addition of the glycols and mucin, and mangiferin can mitigate these modifications, even though
mangiferin-loaded muc-glycoltransfersomes still display a large size. We can hypothesize that the glycols and mucin
interact with the bilayer surface decreasing the repulsion between concentric bilayer and leading to the formation
of multilamellar, large vesicles (as confirmed by cryo-TEM).
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Empty transfersomes 77 ± 9 0.22 -39 ± 7 –
Empty muc-transfersomes 146 ± 32 0.24 -42 ± 6 –
Empty glycoltransfersomes 292 ± 41 0.26 -24 ± 8 –
Empty muc-glycoltransfersomes 238 ± 11 0.26 -60 ± 5 –
Mangiferin transfersomes 73 ± 5 0.22 -56 ± 4 91 ± 5
Mangiferin muc-transfersomes 78 ± 5 0.26 -43 ± 3 94 ± 7
Mangiferin glycoltransfersomes 98 ± 33 0.16 -72 ± 4 92 ± 3
Mangiferin muc-glycoltransfersomes 212 ± 15 0.25 -61 ± 5 91 ± 4
Mean values ± standard deviations are reported (n = 6).
The PI of all the formulations was ≤0.26, confirming the formation of monodispersed systems. The ZP was
always highly negative, especially for mangiferin-loaded glycoltransfersomes (>-60 mV). All the vesicles were able
to load mangiferin in good yields, as indicated by the entrapment efficiency values (>92%), without significant
differences among the formulations (p > 0.05).
In order to evaluate the stability of the vesicles during storage, the dispersions were stored at 25◦C in the dark
for 6 months, and their size, PI and ZP were measured at scheduled times (Figure 2). The study showed a good
stability: the MD of transfersomes and muc-transfersomes increased up to approximately 115 nm already after
3 months, while that of glycoltransfersomes and muc-glycoltransfersomes remained constant, which points to a
positive contribution of glycols to vesicle stability. In particular, results underlined that mucin did not interfere
with the transferosomes assembly, while the combination of glycols and mucin led to a significant increase in vesicle
size, even though the effect of the polymer on vesicle stability was negligible as the tested parameters remained
unchanged over 6 months of storage. The PI remained almost constant for all the formulations, and the ZP slightly
decreased, still being highly negative (Figure 2 A & B).
Evaluation of skin delivery performances of vesicles
The ability of transfersomes and glycoltransfersomes to enhance the deposition of mangiferin into the skin strata
was evaluated by using Franz diffusion cells and newborn pig skin. The deposited mangiferin was extracted from
the skin and quantified by HPLC (Figure 3).
When mangiferin was applied in a water-glycol blend, the highest amount was found in the SC (∼4%), while
in the deeper strata the overall amount was >0.5%. Lower values were found using transfersomes: the highest
deposition was in the SC, but lower than that provided by the dispersion (∼2%, p < 0.05), with a greater
accumulation in the dermis (∼0.5%). This points to a contribution of the glycols in facilitating the diffusion of
mangiferin toward the deep dermis. The addition of mucin to transfersomes (muc-transfersomes) led to a further
decrease of mangiferin deposition in the SC (∼0.6%, p < 0.05 vs dispersion and transfersomes) and an increase in
the epidermis (∼1.1%, p < 0.05 vs dispersion and transfersomes). The best results were obtained when mangiferin
was loaded in glycoltransfersomes and muc-glycoltransfersomes, which provided similar values (p > 0.05). The
deposition of mangiferin was especially increased in the epidermis (∼5.3%, p < 0.05 vs dispersion, transfersomes
and muc-transfersomes) using both glycoltransfersomes and muc-glycoltransfersomes. In the SC and dermis, the
deposition was approximately 1% using glycoltransfersomes, and 1.5% using muc-glycoltransfersomes. Hence,
the accumulation of mangiferin provided by the glycol-vesicles in epidermis and dermis was approximately five-
to six-fold higher than that obtained using muc-transfersomes, probably due to a synergistic action of glycols and
phospholipid vesicles.
Evaluation of the biocompatibility of vesicles
Fibroblasts, the main cells of human dermis, were incubated with mangiferin-loaded vesicles to evaluate their
biocompatibility. The mangiferin dispersed in a water-glycol blend was used as a reference. The vesicles were used
at different dilutions corresponding to 10, 1, 0.1 and 0.01 μg/ml of mangiferin. When mangiferin in dispersion
was tested at lower concentrations (1, 0.1 and 0.01 μg/ml), the viability of fibroblasts was approximately 130%,
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Figure 2. Mean diameter, polydispersity index and ζ potential of vesicles measured during 6 months of storage at
25◦C. The mean values ± standard deviations (error bars) are reported (n = 6).
which indicates a proliferative effect of the polyphenol, while when the higher concentration (10 μg/ml of
mangiferin) was tested, the viability was approximately 80%, which indicates a slight toxicity of mangiferin at
such concentration. When the mangiferin-loaded transfersomes and muc-transfersomes were used, the behavior
was similar: the viability was approximately 95% using the higher concentration (10 μg/ml) and around 150%
when the lower concentrations (1, 0.1 and 0.01 μg/ml) were used. When the glycoltransfersomes were applied,
cell viability was always >130%, irrespective of the concentration (Figure 4, upper panel). The presence of mucin
in muc-glycoltransfersomes slightly reduced the proliferative effect of mangiferin at the higher concentrations (10
and 1 μg/ml), even though the viability was still around 100%.
Evaluation of the protective effect of the formulations against cell damage caused by oxidative
stress
Given the well-known antioxidant and protective properties of mangiferin, fibroblasts were stressed with hydrogen
peroxide, a strong oxidizing agent, and treated with mangiferin-loaded vesicles to evaluate their ability to counteract
oxidative damage and consequent cell death. A water-glycol dispersion of mangiferin was used as a reference to
estimate the advantages provided by the incorporation in vesicles (Figure 4, lower panel).
After 4 h of incubation, hydrogen peroxide caused an approximate 60% mortality of fibroblasts (40% viability).
The treatment of stressed fibroblasts with the mangiferin dispersion led to a approximately 20% reduction of
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Figure 3. Percentage of mangiferin accumulated in stratum corneum, epidermis and dermis after 24 h of application
of mangiferin in dispersion or loaded into transfersomes, glycoltransfersomes, muc-transfersomes or
muc-glycoltransfersomes. Mean values ± standard deviations are reported (n = 6).
D: Dermis; Ep: Epidermis; SC: Stratum corneum.
mortality (∼60% viability), and the treatment with mangiferin-loaded vesicles prevented cell mortality completely,
as the viability was around 100%, regardless of the formulation tested (p > 0.05 among samples).
Scratch wound healing assay
The ability of the mangiferin formulations to promote the migration and proliferation of fibroblasts was assessed
by producing a linear cut on the cell monolayer and evaluating the closure of the wound during 48 h (Figure 5).
The closure of the lesion in untreated cells was not complete after 48 h. The treatment of the wound with
mangiferin in dispersion stimulated cell proliferation and migration, but at 48 h the scratch was not completely
closed and some areas without cells were still present. A similar behavior was observed using mangiferin-loaded
transfersomes. On the other hand, when mangiferin-loaded glycoltransfersomes, muc-transfersomes and muc-
glycoltransfersomes were used, the closure of the wound was complete already at 32 h.
Evaluation of the protective effect of mangiferin formulations against skin damage
Given the need to reduce the number of animals for ethical issues, only the most promising vesicle formulations
were tested in vivo: mangiferin-loaded glycoltransfersomes, muc-transfersomes and muc-glycoltransfersomes. The
skin of the mice injured by TPA and treated with the mangiferin dispersion appeared severely damaged, similarly to
the skin treated with saline (positive control): it appeared desquamated and covered with necrotic tissue (Figure 6).
The skin of mice treated with mangiferin-loaded muc-transfersomes was almost completely healed, but
still showing some minor lesions. On the other hand, when mangiferin-loaded glycoltransfersomes and muc-
glycoltransfersomes were applied, the skin appeared undamaged by TPA and comparable with untreated skin
(negative control).
The activity of MPO, an enzyme released by neutrophils and macrophages during inflammatory processes,
was measured to evaluate the degree of skin inflammation. The MPO concentration in the tissue inflamed by
TPA application and treated with saline was approximately 50 ng/ml. The treatment with mangiferin dispersion
allowed a decrease of this value to approximately 34 ng/ml (p < 0.05), and the treatment with mangiferin-loaded
muc-transfersomes led to a further decrease (∼25 ng/ml, p < 0.05 vs mangiferin dispersion). The most significant
reduction of MPO was observed when mangiferin-loaded glycoltransfersomes and muc-glycoltransfersomes were
used, reaching values approximately 3.3-fold lower than that of skin treated with saline (∼15 ng/ml, p < 0.05 vs
the other formulations).
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Figure 4. Viability values for fibroblasts. Viability values for fibroblasts treated for 48 h with mangiferin in
dispersion or loaded in vesicles (upper panel). Viability values for fibroblasts stressed for 4 h with hydrogen peroxide
without treatment or stressed with hydrogen peroxide and treated with mangiferin in dispersion or loaded in vesicles
(lower panel). Mean values ± standard deviations (error bars) are reported (n = 12).
Histological examination
The skin tissues excised from mice treated with TPA and the mangiferin formulations were stained with
hematoxylin–eosin and observed under an optical microscope to evaluate the degree of inflammation and ul-
ceration. The skin injured by TPA and treated with saline was characterized by acute inflammation in the dermis
(disordered cell organization), skin ulceration and severe panniculitis (Figure 7B). In the skin treated with the
mangiferin dispersion (Figure 7C), cutaneous ulceration, severe inflammatory infiltration in the dermis and mod-
erate panniculitis were evident. The skin treated with mangiferin-loaded muc-transfersomes (Figure 7E) appeared
healthy, but inflammatory infiltration was evident at the dermal level. In the skin treated with mangiferin-loaded
glycoltransfersomes (Figure 7D) and muc-glycoltransfersomes (Figure 7F), epidermis did not show any lesions and
the inflammatory infiltration at dermal level was moderate.
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Figure 5. Representative optical microscopy images of wound closure in fibroblasts treated with mangiferin in
dispersion or loaded in vesicles during 48 h.
Figure 6. Images of mouse dorsal skin. Representative images of mouse skin: untreated (A), damaged by TPA and
treated with saline (B) or treated with mangiferin in dispersion (C), mangiferin loaded in glycoltransfersomes (D),
muc-transfersomes (E) and muc-glycoltransfersomes (F).
Hence, the histological results confirmed the superior ability of glycoltransfersomes and muc-glycoltransfersomes
to deliver mangiferin to the epidermis and dermis and promote skin regeneration.
Discussion
During recent years, the development of nanosystems for the delivery of natural antioxidants has attracted an
extensive attention due to promising beneficial effects of the resulting nanophytoformulations [45]. Given that,
in this study, mangiferin was loaded in innovative phospholipid vesicles tailored for skin delivery. The most
suitable phospholipid vesicles capable of loading 10 mg/ml of mangiferin were selected based on a preformulation
screening. Different types and amounts of phospholipids, edge activators and cosolvents were explored. Soy
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Figure 7. Representative histological images. Representative histological images of skin sections stained with
hematoxylin–eosin and observed under an optical microscope with magnification 10× (upper panel) and 20× (lower
panel). Untreated skin (A), skin injured by TPA and treated with saline (B) or mangiferin in dispersion (C), mangiferin
loaded in glycoltransfersomes (D), muc-transfersomes (E) and muc-glycoltransfersomes (F).
lecithin (180 mg/ml) was selected as phospholipid, in association with Tween 80 (20 mg/ml), which acts as
edge activator making the bilayer more fluid [46,47]. The mixture of phospholipid, Tween 80 and mangiferin was
hydrated with a water, glycerol and propylene glycol blend (25:25:50, % v/v), which resulted in the production of
glycoltransfersomes characterized by small size and stability over time. We can speculate that propylene glycol acts as
a penetration enhancer promoting the skin delivery capabilities of the vesicles [48], and glycerol exerts moisturizing
and hydrating effects on the skin [49].
Transfersomes, prepared with the same amount of soy lecithin and Tween 80 and hydrated with water, were
used as a reference. Mucin was added to both the transfersomes and glycoltransfersomes to improve the bioadhesive
properties and prolong the residence time in the skin [50].
The glycoltransfersomes were around 100 nm and muc-glycoltransfersomes were around 200 nm. Despite being
larger than transfersomes and muc-transfersomes, glycoltransfersomes and muc-glycoltransfersomes were more
stable, as the size did not change during the storage period, reasonably due to the presence of the glycols and the
multilayered structure of these vesicles.
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The loading of mangiferin in the vesicles induced a reduction of MD and ZP, which indicates an involvement
of the polyphenol in the bilayer assembly. Indeed, the mangiferin is a lipophilic molecule that intercalates in
the bilayer between the phospholipid chains [51]. Thanks to their favorable composition, glycoltransfersomes and
muc-glycoltransfersomes enhanced the delivery of mangiferin to epidermis and dermis, which are the main tissues
involved in the repair process of skin lesions [52]. On the contrary, mangiferin dispersion and transfersomes favored
the accumulation of the polyphenol in the SC. The total amount of mangiferin deposited in the whole skin after
24 h of experiment was around 2% for transfersomes and muc-transfersomes, while using glycoltransfersomes
and muc-glycoltransfersomes, the amount was four-times higher (∼8%), with a predominant accumulation in
epidermis and dermis (∼6%), which was 12-times higher than the amount provided by the aqueous dispersion.
This confirms the enhancing properties of the glycol-vesicles. In addition, it is worthy to note that these results
refer to intact skin, but our formulations are intended for the treatment of injured skin with impaired barrier
function, and hence the delivery of mangiferin is expected to be higher. Indeed, in the in vivo study performed on
damaged skin, glycoltransfersomes and muc-glycoltransfersomes, showed superior carrier performances resulting
in an improved efficacy of mangiferin.
The vesicles were able to effectively counteract the dangerous effects of oxygen free radicals in dermal fibroblasts
and promote their migration and proliferation into the wound site, facilitating its closure. In the in vitro studies
in fibroblasts, all the vesicles promoted the efficacy of mangiferin thanks to their carrier capabilities, irrespective
of their composition, which instead was a key determinant of the performance of the vesicles in skin delivery,
and consequently in the in vivo study. Indeed, the skin treated with mangiferin-loaded glycoltransfersomes and
muc-glycoltransfersomes showed a complete remission of the lesions caused by TPA, which was daily applied onto
the skin to produce an extended wound associated with edematous and inflamed tissue simulating the biochemical
events that naturally occur in in vivo pathological wounds [53,54]. The superior performance of glycoltransfersomes
can be reasonably ascribed to the glycols, which were not present in transfersomes. It has to be noted that the effect
of mucin was negligible. The glycols are supposed to be located both within the vesicles and in the intervesicle
medium, and when they come into contact with the skin surface, they promote hydration and perturb the SC
barrier, acting synergistically with the phospholipid and the edge activator, thus facilitating the passage of intact
vesicles.
Conclusion
Results disclosed the optimal performances of glycoltransfersomes in delivering mangiferin to damaged skin,
potentiating its wound healing properties and confirming the value of the applied formulation strategy. Indeed,
the two used water cosolvents, glycerol and propylene glycol, exert a synergistic activity with the elastic vesicles
(transfersomes), improving their well-known ability to overcome the biological membranes. These novel carriers
maximize the efficacy of mangiferin in tissue regeneration, thus representing promising formulations for wound
healing.
Summary points
• Tween 80, glycerol and propylene glycol were used to formulate glycoltransfersomes.
• Mangiferin, a natural antioxidant, was incorporated in glycoltransfersomes.
• Glycoltransfersomes were modified by adding mucin to increase their performances.
• Both glycoltransfersomes and mucin-glycoltransfersomes promoted the deposition of mangiferin in epidermis
and dermis.
• The vesicles were cytocompatible and capable of protecting fibroblasts from oxidative stress.
• The vesicles stimulated fibroblasts’ proliferation and migration leading to wound closure in vitro.
• The vesicles protected mouse skin from chemically induced injury.
• The vesicles reduced inflammatory infiltration and promoted skin regeneration in mice.
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40. Caddeo C, Sales OD, Valenti D, Sauŕı AR, Fadda AM, Manconi M. Inhibition of skin inflammation in mice by diclofenac in vesicular
carriers: liposomes, ethosomes and PEVs. Int. J. Pharm. 443(1–2), 128–136 (2013).
41. Dermatological and Transdermal Formulations. Walters KA. (Ed.). CRC Press, FL, USA (2019).
42. Manca ML, Valenti D, Sales OD, Nacher A, Fadda AM, Manconi M. Fabrication of polyelectrolyte multilayered vesicles as inhalable dry
powder for lung administration of rifampicin. Int. J. Pharm. 472(1–2), 102–109 (2014).
43. Klemetsrud T, Jonassen H, Hiorth M, Kjøniksen AL, Smistad G. Studies on pectin-coated liposomes and their interaction with mucin.
Colloids Surf. B Biointerfaces 103, 158–165 (2013).
44. Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Novel mucoadhesion tests for polymers and
polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv. Drug Deliv. Rev. 57(11), 1583–1594 (2005).
45. Van Tran V, Moon J, Lee Y. Liposomes for delivery of antioxidants in cosmeceuticals: challenges and development strategies. J. Control.
Rel. 300, 114–140 (2019).
1684 Nanomedicine (Lond.) (2020) 15(17) future science group
Innovative strategies to treat skin wounds with mangiferin: fabrication of transfersomes modified with glycols & mucin Research Article
46. Benson HAE. Transfersomes for transdermal drug delivery. Expert Opin. Drug Deliv. 3(6), 727–737 (2006).
• Uses this paper as reference because it shows the properties of mucin and its use in nanomedicine.
47. Ahad A, Al-Saleh AA, Al-Mohizea AM et al. Formulation and characterization of Phospholipon 90 G and Tween 80 based transfersomes
for transdermal delivery of eprosartan mesylate. Pharm. Dev. Technol. 23(8), 787–793 (2018).
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